Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals Ownership Summary
Madrigal Pharmaceuticals is owned by 103.91% institutional investors, 8.57% insiders. Janus henderson group is the largest institutional shareholder, holding 12.43% of MDGL shares. Janus Concentrated Growth CF is the top mutual fund, with 2.90% of its assets in Madrigal Pharmaceuticals shares.
MDGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Madrigal Pharmaceuticals | 103.91% | 8.57% | -12.48% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 2.49M | 12.43% | $696.33M |
| Avoro capital advisors | 2.06M | 10.28% | $575.88M |
| Baker bros. advisors lp | 1.97M | 9.87% | $553.20M |
| Rtw investments, lp | 1.92M | 9.58% | $536.75M |
| Paulson | 1.85M | 9.25% | $518.30M |
| Vanguard group | 1.71M | 7.85% | $526.46M |
| Blackrock | 1.43M | 7.14% | $399.86M |
| Blackrock funding, inc. /de | 1.49M | 6.87% | $461.06M |
| Price t rowe associates inc /md/ | 858.76K | 4.29% | $240.59M |
| Fmr | 789.00K | 3.94% | $221.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Paulson | 1.85M | 38.31% | $518.30M |
| Tao capital management lp | 130.53K | 29.98% | $36.57M |
| University of wisconsin foundation | 45.73K | 14.42% | $12.81M |
| Alpinvest partners b.v. | 84.59K | 8.50% | $23.70M |
| Rtw investments, lp | 1.92M | 8.31% | $536.75M |
| Propel bio management | 43.03K | 7.82% | $12.06M |
| Avoro capital advisors | 2.06M | 7.67% | $575.88M |
| Baker bros. advisors lp | 1.97M | 7.07% | $553.20M |
| Tri locum partners lp | 65.35K | 4.63% | $18.31M |
| Affinity asset advisors | 110.00K | 3.55% | $30.82M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | 1.92M | 8.31% | 1.52M |
| William blair investment management | 371.77K | 0.28% | 371.77K |
| Blackrock | 1.43M | 0.01% | 216.86K |
| Arrowmark colorado | 187.39K | 0.63% | 153.17K |
| State street | 744.71K | 0.01% | 119.78K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -264.60K |
| Ra capital management | - | - | -204.50K |
| Bain capital life sciences investors | - | - | -197.00K |
| 683 capital management | 11.50K | 0.24% | -166.40K |
| Tcg crossover management | - | - | -149.28K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| William blair investment management | 371.77K | 0.28% | 371.77K | $114.72M |
| Norges bank | 115.09K | 0.00% | 115.09K | $35.51M |
| Raymond james financial | 53.85K | 0.01% | 53.85K | $16.62M |
| Proficio capital partners | 17.28K | 0.00% | 17.28K | $17.28K |
| Kornitzer capital management inc /ks | 14.76K | 0.09% | 14.76K | $4.55M |
Sold Out
| Holder | Change |
|---|---|
| Atlas capital advisors | -1.00 |
| Cva family office | -2.00 |
| Innealta capital | -2.00 |
| Riggs asset managment | -2.00 |
| Capital performance advisors llp | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 281 | -1.75% | 22,596,992 | -0.11% | 103 | 0.81% | 128 | -20.99% | 87 | 31.82% |
| Jun 30, 2024 | 286 | -7.44% | 22,622,141 | 8.92% | 113 | 1.05% | 162 | -1.22% | 66 | -20.48% |
| Mar 31, 2024 | 309 | 20.70% | 20,769,053 | 6.81% | 103 | 0.96% | 164 | 9.33% | 83 | 38.33% |
| Dec 31, 2023 | 256 | 11.30% | 19,444,323 | 14.35% | 104 | 1.23% | 150 | 21.95% | 60 | 3.45% |
| Sep 30, 2023 | 230 | -2.95% | 17,003,801 | 14.19% | 92 | 1.39% | 123 | -5.38% | 58 | 3.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Janus Concentrated Growth CF | 632.30K | 2.90% | 66.37K |
| Janus Henderson Forty S | 632.30K | 2.90% | 66.37K |
| Vanguard Total Stock Mkt Idx Inv | 515.68K | 2.36% | -57.97K |
| iShares Russell 2000 ETF | 487.59K | 2.24% | -3.70K |
| Vanguard Small Cap Index | 416.58K | 1.91% | -48.96K |
| SPDR® S&P Biotech ETF | 357.24K | 1.64% | -3.48K |
| Janus Henderson Opportunistic Alpha MA | 319.65K | 1.47% | 319.62K |
| Janus Henderson US Opportunistic Alpha | 319.65K | 1.47% | - |
| Janus Henderson Contrarian D | 319.65K | 1.47% | - |
| Vanguard Small Cap Value Index Inv | 276.60K | 1.27% | -38.17K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 24, 2025 | Huntsman Carole | Chief Commercial Officer | Sell | $116.33K |
| Jan 24, 2025 | Sibold William John | President and CEO | Sell | $531.02K |
| Jan 24, 2025 | Taub Rebecca | Pres., R&D, and CMO | Sell | $217.24K |
| Jan 24, 2025 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sell | $34.53K |
| Jan 17, 2025 | Kelley Shannon T | General Counsel | Sell | $75.73K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 10 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 104 |
| 2024 Q1 | 2 | - |
MDGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools